| Literature DB >> 31156335 |
Dorota Kostrzewa-Nowak1,2, Rafał Buryta1,2,3, Robert Nowak1,2.
Abstract
BACKGROUND: Immunological alterations may led to the reduction in capacity and endurance levels in elite athletes by e.g. increased susceptibility to infections. There is a need to explain the impact of intensive physical effort on the CD4+ memory T cell subsets.Entities:
Keywords: cytokines; elite soccer players; flow cytometry; lymphocytes; maximal effort
Year: 2019 PMID: 31156335 PMCID: PMC6534948 DOI: 10.2478/jomb-2018-0029
Source DB: PubMed Journal: J Med Biochem ISSN: 1452-8266 Impact factor: 3.402
A baseline characteristic of the participants.
| The beginning of preparatory phase to spring competition round | The beginning of preparatory phase to autumn competition round | |
|---|---|---|
| Age [years] | 19 (17 – 21) | 18 (17 – 21) |
| Height [cm] | 181 (172 – 187) | 179 (172 – 184) |
| Weight [kg] | 72.4 (63.3 – 81.3) | 69.7 (63.3 – 73.1) |
| BMI [kg/m2] | 22.6 (21.6 – 23.8) | 21.5 (20.8 – 23.0) |
| BMR [kJ] | 8686 (7242 – 8782) | 7880 (7314 – 8297) |
| FAT [%] | 10.6 (6.4 – 13.1) | 9.0 (7.1 – 10.6) |
| FAT MASS [kg] | 7.90 (4.10 – 10.15) | 6.3 (4.1 – 7.9) |
| FFM [kg] | 66.2 (57.4 – 70.6) | 63.5 (58.6 – 67.1) |
| TBW [kg] | 48.5 (42.1 – 51.7) | 46.5 (42.9 – 49.1) |
| length of training experience [years] | 12 (11 – 12) | 11.5 (11 – 12) |
| weekly training volume [hours] | 10 (9 – 12) | 10.5 (10 – 12) |
The table presents median (Q1-Q3) values (except for the age, where median (min-max) is presented) characterising the participants. Body mass and body composition were determined using Body Composition Analyzer Tanita BC-418MA (Tanita, Tokyo, Japan). n – number of participants, BMI – body mass index, BMR – basal metabolic rate, FAT – percentage of fat, FFM – fat free mass, TBW – total body water.
The cardiorespiratory fitness measures of participants during the progressive test until exhaustion.
| The beginning of preparatory phase to spring competition round | The beginning of preparatory phase to autumn competition round | |
|---|---|---|
| VO2max [mL/kg/min] | 59.05 (56.55 – 62.03) | 60.80 (58.40 – 64.40) |
| HRmax [beats/min] | 193 (188 – 201) | 204 (190 – 210) |
| AT [beats/min] | 163 (156 – 169) | 166 (161 – 181) |
| RQ | 1.03 (1.02 – 1.06) | 1.08 (1.07 – 1.09)* |
| RC | 176 (169 – 183) | 187 (173 – 193) |
| VE [L/min] | 108.5 (99.1 – 127.3) | 150.4 (122.2 – 160.9)* |
| MVV [L/min] | 189.5 (176.2 – 194.4) | 188.2 (172.5 – 201.1) |
| MET [mL/kg/min] | 16.5 (16.1 – 16.9) | 17.3 (16.7 – 18.4) |
| Rf | 49.7 (42.4 – 52.4) | 61.5 (56.1 – 67.5)* |
The table presents median (Q1-Q3) values. The analyses were performed using state-of-the-art breath by breath gas exchange data analyser Quark CPET (Cosmed, Albano Laziale, Italy).
n – number of participants, VO2max – maximum oxygen uptake; HRmax – maximum heart rate; AT – anaerobic threshold; RQ – respiratory quotient (volume ratio of emitted CO2 to oxygen uptake); RC – respiratory compensation; VE – minute ventilation; MVV – maximal voluntary ventilation; MET – metabolic equivalent; Rf – respiratory frequency. Significance level of differences observed between spring and autumn experiment was calculated using Wilcoxon’s matched-pairs test. *P < 0.05.
Selected haematological and biochemical parameters of participants during the progressive test until exhaustion.
| The beginning of preparatory phase to spring competition round | The beginning of preparatory phase to autumn competition round | |||||
|---|---|---|---|---|---|---|
| Pre-exercise | Post-exercise | Recovery | Pre-exercise | Post-exercise | Recovery | |
| WBC [109/L] | 5.5 a)*** (5.1 – 6.0) | 7.8 b)* (6.2 – 10.0) | 6.2 (5.6 – 6.8) | 6.4 a)** (5.8 – 7.0) | 9.0 b)**** (7.7 – 11.3) | 5.8 (5.1 – 6.1) |
| LYM [109/L] | 1.6 a)* (1.1 – 1.9) | 2.7 (1.9 – 3.4) | 1.6 (1.4 – 2.1) | 1.9 a)** (1.8 – 2.2) | 3.3 b)*** (2.9 – 4.0) | 1.8 (1.7 – 2.1) |
| Total protein [g/L] | 69.43 a)*** (67.64 – 71.92) | 71.06 b)* (67.73 – 76.16) | 67.29 (64.42 – 69.13) | 71.69 a)** (69.34 – 72.29) | 75.26 b)***** (73.70 – 75.78) | 69.30 (67.50 – 71.01) |
| CK [U/L] | 262.0 a)* (239.1 – 440.7) | 354.1 (285.2 – 504.7) | 484.2 c)** (368.6 – 564.5) | 185.7 a)** (116.0 – 248.1) | 226.4 (139.1 – 370.3) | 322.1 c)*** (276.4 – 411.2) |
The table presents median (interquartile range) values. The analyses were performed using haematology analyser ABX Micros 60 (Horiba ABX, Warsaw, Poland) or Auto Chemistry Analyser BM-100 (BioMaxima S.A., Lublin, Poland), respectively.
Significance level of differences observed between analysed time points (pre-exercise vs. post-exercise vs. recovery) was assessed using Friedman’s analysis of variance followed by post-hoc Dunn’s test with Bonferroni correction.
WBC, number of white blood cells; LYM, number of lymphocytes; CK, creatine kinase activity.
The results of post-hoc analyses: a) pre-exercise vs. post-exercise, b) post-exercise vs. recovery, c) pre-exercise vs. recovery * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001; ***** P < 0.00001 n – number of participants.
The plasma cytokine profile of participants during the progressive test until exhaustion.
| The beginning of preparatory phase to spring competition round | The beginning of preparatory phase to autumn competition round | |||||
|---|---|---|---|---|---|---|
| Pre-exercise | Post-exercise | Recovery | Pre-exercise | Post-exercise | Recovery | |
| TNF-α [pg/mL] | 1.79 a)** (1.39 – 2.20) | 2.98 (2.60 – 3.33) | 2.72 c)* (2.22 – 3.06) | 1.90 a)* (1.68 – 2.05) | 2.94 b)**** (2.68 – 3.08) | 1.53 (1.34 – 1.57) |
| IL-8 [pg/mL] | 14.47 a)* (13.47 – 15.53) | 26.02 b)*** (23.47 – 28.14) | 12.62 (11.49 – 13.54) | 13.62 a)** (13.15 – 14.60 | 25.28 b)**** (23.76 – 26.38) | 12.34 (11.97 – 13.16) |
| IL-6 [pg/mL] | 12.26 (11.68 – 13.68) | 12.30 b)* (11.75 – 13.19) | 20.22 c)** (20.00 – 21.56) | 11.91 (11.1 – 11.79 | 11.37 b)*** (11.03 – 11.76) | 22.19 c)*** (21.64 – 22.64) |
| 2.84 (2.78 – 3.30) | 2.99 b)** (2.26 – 3.06) | 5.57 c)** (5.29 – 6.09) | 0.83 (1.78 – 0.57) | 1.02 b)** (0.77 – 1.25) | 2.15 c)*** (1.99 – 2.28) | |
| IL-12p70 [pg/mL] | 2.12 (1.98 – 2.20) | 1.66 (1.20 – 2.06) | 1.09 c)** (0.98 – 1.21) | 2.00 a)**** (1.88 – 2.21) | 0.54 b)* (0.51 – 0.78) | 1.10 c)* (0.97 – 1.28) |
The table presents median (Q1-Q3) values.
The analyses were performed using BD Cytometric Bead Array (CBA) Human Inflammatory Cytokines Kit and BD Accuri™ C6 flow cytometer.
Significance level of differences observed between analysed time points (pre-exercise vs. post-exercise vs. recovery) was assessed using Friedman’s two-way analysis of variance followed by post-hoc Dunn’s test with Bonferroni correction.
The results of post-hoc analyses:
a) pre-exercise vs. post-exercise
b) post-exercise vs. recovery
c) pre-exercise vs. recovery
* P < 0.05; ** P < 0.01; ***P < 0.001; **** P < 0.0001
n – number of participants.